Negative control by Sandostatin on pancreatic and duodenal growth: a possible implication of insulin-like growth factor I
- 11 June 1991
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 34 (1) , 13-23
- https://doi.org/10.1016/0167-0115(91)90220-b
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Insulin-like growth factor-I concentration in Holstein female cattle: variations with age, stage of lactation and growth hormone-releasing factor administrationDomestic Animal Endocrinology, 1990
- The Long-Acting Somatostatin Analogue SMS 201-995 Causes MalabsorptionScandinavian Journal of Gastroenterology, 1989
- Effect of a New CCK-Receptor Antagonist, CR 1409, on Pancreatic Growth Induced by Caerulein, CCK-8, Bombesin and Gastrin-Releasing Peptide in the RatDigestion, 1989
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- Gastrointestinal somatostatin: Distribution, secretion and physiological significanceLife Sciences, 1985
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Effect of Fasting and Somatostatin Administration on Circadian Rhythms of Jejunal Cell Renewal and Plasma Gastrin Level in RatsDigestion, 1982
- Effects of short-term and prolonged infusions of somatostatin on endocrine pancreas, body weight and food intake in ratsActa Physiologica Scandinavica, 1980
- Evidence that somatomedin is synthesized by multiple tissues in the fetusDevelopmental Biology, 1980
- INHIBITION OF CHOLECYSTOKININ-PANCREOZYMIN RELEASE BY SOMATOSTATINThe Lancet, 1977